Active Role in Cancer Diagnosis and Treatment Spurs Use of Radiopharmaceuticals, Market to Rise Exponentially
Radiopharmaceuticals are a group of pharmaceutical drugs that have radioactivity. They are used for the diagnosis and treatment of various diseases such as tumors, cancers, and diseases affecting the bone marrow, heart, kidney, liver, lungs, salivary gland, and urinary bladder. The market for radiopharmaceuticals is expanding owing to the increasing rate of chronic cardiovascular and neurology diseases and will be worth US$12.2 bn by 2018, expanding at a whopping CAGR of 18.3%, according to a report published by Transparency Market Research.
View full press release